Coinbase now offers staking rewards for Cosmos token

Crypto exchange Coinbase is now offering rewards for staking ATOM, the native token of the Cosmos blockchain network.

ATOM is the second token Coinbase supports for staking rewards, after Tezos (XTZ). The exchange said customers in select jurisdictions — the U.S., the U.K., France, Spain, Netherlands, and Belgium — could start earning a 5% return per annum for staking ATOM.

Coinbase charges a 25% commission for staking ATOM, the same as for XTZ, a spokesperson of the exchange told The Block. "We take a commission on all rewards received, and the return rate for our customers reflects this commission," the spokesperson explained. 

THE SCOOP

Keep up with the latest news, trends, charts and views on crypto and DeFi with a new biweekly newsletter from The Block's Frank Chaparro

By signing-up you agree to our Terms of Service and Privacy Policy
By signing-up you agree to our Terms of Service and Privacy Policy

Despite charging a higher commission, Coinbase is the biggest Tezos staking service, as The Block reported recently. Coinbase said it has distributed more than $2 million worth of Tezos rewards to customers since the service was first launched in November 2019.

ATOM staking rewards would get credited every seven days, while XTZ rewards get credited every three days.

Looking ahead in the coming year, Coinbase said customers could expect to see more tokens being supported for staking rewards. 

About Author

Yogita Khatri is a senior reporter at The Block, covering all things crypto. As one of the earliest team members, Yogita has played a pivotal role in breaking numerous stories, exclusives and scoops. With nearly 3,000 articles under her belt, Yogita holds the records as The Block's most-published and most-read author of all time. Prior to joining The Block, Yogita worked at crypto publication CoinDesk and The Economic Times, where she wrote on personal finance. To contact her, email: [email protected]. For her latest work, follow her on X @Yogita_Khatri5.